Demographics (3)
- AGE - Subject age at enrollment (phv00527625.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00527634.v1.p1)
- SEX - Biological sex (phv00527620.v1.p1)
Disease Events (1)
- AFFECTION_STATUS - Case control status of the subject for acute myeloid leukemia (AML) (phv00527624.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00527631.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00527630.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00527619.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00527633.v1.p1)
- IS_TUMOR - Tumor status (phv00527632.v1.p1)
- KMT2C - Somatic mutation in KMT2C (Entrez GeneID: 58508) (phv00527628.v1.p1)
- KRAS - Somatic mutation in KRAS (Entrez GeneID: 3845) (phv00527626.v1.p1)
- NRAS - Somatic mutation in NRAS (Entrez GeneID: 4893) (phv00527627.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00527635.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00527636.v1.p1)
- SAMPLE_ID - Sample ID (phv00527629.v1.p1)
- SAMPLE_ID - Sample ID (phv00527622.v1.p1)
- SUBJECT_ID - Subject ID (phv00527623.v1.p1)
- SUBJECT_ID - Subject ID (phv00527618.v1.p1)
- SUBJECT_ID - Subject ID (phv00527621.v1.p1)